NCT03461458 - Autologous, Culture-Expanded Mesenchymal Stromal Cells for Degenerative Disc Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 17, 2018

Primary Completion Date

February 6, 2021

Study Completion Date

February 6, 2021

Conditions

Degenerative Disc Disease

Interventions

DRUG

Autologous Adipose-Derived Mesenchymal Stromal Cells

Human, autologous, culture expanded, adipose-derived, mesenchymal stromal cells (AMSCs) produced on site in the Mayo Clinic Immune Progenitor and Cell Therapeutics Laboratory using current good manufacturing practices (cGMPs).

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester